Latest Posts

9

Feb 23

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary...
Read More
Bad-hearsfeld

4

Aug 22

OncoCoin AG donates for a charity bicycle tour: Tour of Hope

Bad Hersfeld / Germany, Aug 02, 2022– Mayor Thomas Fehling took the opportunity at the Smart City Forum, which took...
Read More

Archives: News

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros

The treatment and support of patients with advanced tumor diseases is a complex task involving numerous disciplines. For the interdisciplinary medical exchange, there are so-called tumor boards, in which the physicians discuss the treatment strategy. For this purpose, a large amount of medical data is available for each individual patient, which must be evaluated individually …

AI supports targeted therapy recommendations fortumor diseases – BMBF funds joint research projectat University Medical Center Mainz with 2.53 millionEuros Read More »

Innoplexus-Innovatrix-partnership

Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry

Artificial Intelligence (AI) pioneer Innoplexus and London based Parametric Insurance start-up, Innovatrix Capital, collaborating upon using AI & Machine Learning (ML) to bring about new risk-transfer solutions for the life science industry. Eschborn, Germany/London, U.K., 27 July 2022Innoplexus AG is pleased to announce that an agreement for a strategic partnership with Innovatrix Capital Ltd. has …

Innoplexus and Innovatrix capital partner to bring about new risk-transfer solutions for the life science industry Read More »

Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence

Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence to expedite PIM kinase inhibitor development ESCHBORN, Germany, May 30, 2022 – Innoplexus, a global leader in AI-based drug discovery and development, and Inflection Biosciences Ltd., an innovative biotechnology company focused upon developing innovative small molecule therapeutics for the treatment of cancer, autoimmune and …

Innoplexus and Inflection Biosciences enter strategic collaboration based on Artificial Intelligence Read More »

Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform

COVID-19 Clearinghouse is the go-to platform for directly accessing the latest information and research about the coronavirus and COVID-19. ESCHBORN, Germany, Boston, M.A. and Durham, N.C., May 11, 2021 – Innoplexus, a global leader in AI-based drug discovery and development, and Parexel, a leading global clinical research organization, have expanded the features and functionality of their COVID-19 Clearinghouse platform …

Innoplexus and Parexel Expand Capabilities of COVID-19 Information Platform Read More »

Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic

COVID-19 Clearinghouse enables direct access to latest COVID-19 datasets, publications, research and clinical trials BOSTON and DURHAM, N.C. and ESCHBORN, Germany, Sept. 24, 2020 (GLOBE NEWSWIRE) — Parexel, a leading provider of solutions to accelerate the development and delivery of innovative new therapies to market to improve world health, from Clinical through Commercialization, in collaboration …

Parexel and Innoplexus Unveil Single Source of COVID-19 Information for Researchers, Sponsors and Patients During the Pandemic Read More »

Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will

Die Eschborner Firma Innoplexus ist so etwas wie das Google für die Pharmaindustrie. Firmenchef Gunjan Bhardwaj erklärt, wie künstliche Intelligenz beim Kampf gegen Covid-19 und Krebs helfen kann. Eine Prognose, wann ein wirksames Mittel auf den Markt kommen kann, wagt er nicht. Beim Börsengang sieht das aber schon anders aus. WELT: Herr Bhardwaj, Ihr Unternehmen Innoplexus …

Wie das „Google der Pharmaindustrie“ den Kampf gegen Corona gewinnen will Read More »

Der Pharma-Visionär

Mit künstlicher Intelligenz gegen Krankheiten: Wie Gunjan Bhardwaj die Regeln der Arzneimittelforschung umschreiben will – für schnellere Ergebnisse und bessere Medikamente. Der Rollkoffer steht schon bereit. Ein kleiner, schwarzer Trolley, für einen Kurztrip – nach Indien, der Heimat von Gunjan Bhardwaj. Bevor es losgeht, erzählt der „indische Schwabe“ (so nennt er sich) aber noch, wie …

Der Pharma-Visionär Read More »

Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona

Hessen fördert Forschungsprojekt mit rund 1,4 Mio. Euro. Mit einem Zuschuss von 1,4 Mio. Euro unterstützt Hessen die Entwicklung eines Wirkstoffkandidaten gegen SARS-CoV-2 mit Hilfe Künstlicher Intelligenz. Das Projekt des Eschborner Unternehmens Innoplexus soll die Suche nach neuen Wirkstoffen erheblich verkürzen, indem es Forschungsergebnisse weltweit sammelt und mit Hilfe Künstlicher Intelligenz auswertet. „Die Pharmabranche zählt …

Künstliche Intelligenz unterstützt Suche nach Wirkstoff gegen Corona Read More »